Department of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Clin Transl Oncol. 2019 Jul;21(7):819-827. doi: 10.1007/s12094-018-02007-5. Epub 2018 Dec 17.
Breast is one of the most common primary origins of secondary ovarian cancer. There are some factors that influence the incidence of ovarian metastases (OM), such as histological type of primary cancer. OM from breast cancers are frequently asymptomatic until the masses have grown to certain size, and the metastatic tumors are frequently manifested as bilateral, solid, small ovarian masses. On the other hand, patients with a history of breast cancer have an increased risk of developing primary ovarian cancer (POC) than the general population. To differentiate OM from POC is essential as the optimal treatments and prognosis are distinct. Medical history, clinical manifestation, imaging examinations, serological examinations, and pathology (including immunohistochemical, genomic and transcriptomic approach) are all essential elements to improve the diagnostic accuracy. Breast cancer patients with OM have a poor prognosis; surgical resection with systemic therapy may help prolong the survival.
乳房是卵巢癌继发转移的最常见原发部位之一。有一些因素会影响卵巢转移瘤(OM)的发生率,如原发性癌症的组织学类型。乳腺癌引起的 OM 通常在肿块长到一定大小之前没有症状,转移瘤常表现为双侧、实性、小的卵巢肿块。另一方面,与普通人群相比,有乳腺癌病史的患者发生原发性卵巢癌(POC)的风险增加。区分 OM 和 POC 很重要,因为它们的最佳治疗方法和预后截然不同。病史、临床表现、影像学检查、血清学检查和病理学(包括免疫组织化学、基因组和转录组方法)都是提高诊断准确性的必要因素。患有 OM 的乳腺癌患者预后较差;手术切除联合全身治疗可能有助于延长生存期。